Archive for the Packard Foundation Category

Abortion groups tell women to lie about abortion pill, claim miscarriage

Posted in Abortion pill, Abortion Pills Illegal, DANCO, Packard Foundation, Self Managed Abortion, self-managed abortion with tags , , , , , , , , , , , , , , , , , , , on June 2, 2019 by saynsumthn

abortion pill

Just as abortion supporters rage over new pro-life laws in Georgia and Alabama, claiming that women could be investigated for miscarriages, comes proof that abortion supporters are actually advising women who experience complications from illegal use of the abortion pill to lie to health care providers and say they had miscarriages.

Currently, abortion insiders, many with ties to abortion pill manufacturer Danco, are pushing for expansion of the abortion pill, despite thousands of adverse effects and two dozen deaths. The abortion pill regimen consists of two drugs: Mifepristone  (or Mifeprex) and Misoprostol. The FDA has warned women against purchasing these dangerous pills online.

Dr. Daniel Grossman, a professor of obstetrics and gynecology at the University of California, San Francisco, who also teaches abortion allegedly told a reporter at The Atlantic that if women using these [self-managed abortion] regimens experience heavy bleeding or some other complication, they are generally advised to go to a hospital and say they had a miscarriage.

Grossman is behind clinical trials to expand the abortion pill for pharmacy dispension and is calling to remove important safety requirements put in place by the FDA, called REMS. This comes as no surprise, as one of the major original investors of abortion pill manufacturer Danco — The Packard Foundation — has funded other Grossman-authored studies. In other words, those behind the studies attempting to do away with FDA safety requirements for the abortion pill stand to gain a significant amount of money if those requirements are removed.

Image: Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )

Packard Foundation invested in abortion pill manufacturer DANCO (Image: David and Lucile Packard Foundation )


If you think you might have a complication you should go to a doctor immediately. If you live in a place where abortion is a crime and you don’t have a doctor you trust, you can still access medical care. You do not have to tell the medical staff that you tried to induce an abortion; you can tell them that you had a spontaneous miscarriage. Doctors have the obligation to help in all cases and know how to handle a miscarriage.
The international abortion organization, Women on Web, advises women on its website to present to the ER and claim they are having a miscarriage if they experience complications from the abortion pill in a country where taking the drug is illegal:

The symptoms of a miscarriage and an abortion with pills are exactly the same and the doctor will not be able to see or test for any evidence of an abortion, as long as the pills have completely dissolved. 

Women on Web advises women lie about illegal abortion pill emergencies say miscarriage (accessed 5/14/2019)

According to a report from The Atlantic, Women on Web’s founder, Rebecca Gomperts, launched the site Aid Access to sell the abortion pill online, against FDA requirements. The FDA recently issued Aid Access a warning letter to cease its illegal activity. Last week, over 100 lawmakers sent a letter to the FDA, asking it to continue to monitor and crack down on dangerous websites like Aid Access.

But that has not stopped other proponents of self-managed abortion, who seem set on placing women in harm’s way. The website Plan C, founded in 2015 by Francine Coeytaux and Elisa Wells, tells women, “Those who choose to self-manage their abortion have no obligation to report that they have used misoprostol and there is no way it can be detected in the body, even if a blood test is taken. Scientists have found that there is no noticeable difference between a naturally occurring miscarriage and the bleeding that happens after taking misoprostol.”

Plan C Website FAQ where get

Then, if something goes wrong (and it most likely will), the Plan C website, which is under the fiscal sponsorship of the National Women’s Health Network, advises women to present to the emergency room or other health care offices and simply claim they are experiencing a miscarriage.

PlanC website tells women aborting to present with Miscarriage, accessed 5/14/2019

Live Action News previously reported how abortion organization, Reproaction, purchased over $4,000 in ads to promote a push for self-managed abortion — something unapproved by the FDA. Reproaction also advises women to seek care by lying about their abortions.

A webinar published in 2018 states in part that women “need information to reduce the risk of arrest… what the signs of a complication are and most importantly what to say if one needs to go to the doctor…. [T]he symptoms of an abortion with pills and miscarriage are exactly the same and the treatment for any kind of complication is exactly the same…. It’s important for people to understand there’s no test for these pills in blood or urine so if they present with a miscarriage they can get the healthcare that they need….”

tweet from “Helen Bolton” — whose profile implies that he or she is with organized abortion groups “ and ” — reiterates the deception being proposed: “Misoprostol is basically OTC in a lot of the world and is regularly used to self-manage abortions in places where it’s illegal. Even with complications, the patient looks like they had a miscarriage, so people can go to a hospital (provided miscarriages aren’t investigated).”

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

Others have made similar suggestions.

Abortion supporter advises women lie about illegal abortion pill emergencies say miscarriage (Image: Twitter)

FDA warns women: “Do Not Buy Mifeprex Over the Internet.

FDA warns consumers to not buy abortion pills over the internet

The FDA adds, “You should not buy Mifeprex over the Internet because you will bypass important safeguards designed to protect your health (and the health of others). Mifeprex has special safety restrictions on how it is distributed to the public. Also, drugs purchased from foreign Internet sources are not the FDA-approved versions of the drugs, and they are not subject to FDA-regulated manufacturing controls or FDA inspection of manufacturing facilities.”

According to the FDA’s adverse effects reports through 2018, there have been reports of 24 deaths associated with Mifeprex since the product was approved in September 2000, as well as 4,200 reported adverse effects, including hospitalization and other serious complications.

  • This article is reprinted with permission. The original appeared here at Live Action News.

Taxpayers send millions to abortion training program at UCSF

Posted in Abortion Pill Connections, Abortion Pill Study, Abortionist, Abortionist Training, Bill Gates, Fellowship in Family Planning (FFP), Hewlett Foundation, Innovating Education in Reproductive Health, National Abortion Federation, Packard Foundation, Philip Darney, Ryan Residency, Uta Landy with tags , , , , , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

Who’s paying millions for this abortion training program? Taxpayers.

third trimester abortion, abortion training

Abortion training is being orchestrated out of a University of California, San Francisco (UCSF) program which receives millions in government dollars. UCSF trains abortion providers through their Bixby Center for Global Reproductive Health , which claims to be “one of the few research institutions to unflinchingly address abortion, investigating multidimensional aspects of abortion care in the United States and globally.” Bixby claims their work has:

According to Bixby’s annual reports, in 2014, nearly $22 million dollars (52 percent) of Bixby’s revenue came from the taxpayer, although the report does not specify whether the funds were state or federal. By 2015, although Government dollars made up only 18 percent of Bixby’s revenue, it totaled over $18 million in taxpayer dollars. Bixby is conveniently located in California, which permits millions in taxpayer dollars to fund abortions and has no requirement that abortion numbers be reported to the Centers for Disease Control (CDC) for data analysis.

UCSF Bixby Gov Funding 18 million in 2015 to 2016 AR

Taxpayer dollars sent to UCSF for fetal research include millions from the National Institutes of Health (NIH). A recent report published by CNS News breaks down the dollars of the multi-year contract:

[T]he Department of Health and Human Services has granted contracts to UCSF to make “humanized mice.”… According to contract information published on the Federal Procurement Data System, the new three-month extension will pay UCSF $521,082—bringing the total payments the federal government has made to UCSF for this contract to $10,596,960. If the government continues renewing the contract through Dec. 5, 2020, HHS would end up paying UCSF a total of $13,799,501.

In addition to government (taxpayer) dollars, Bixby receives funding from a number of organizations collaborating to expand abortion, such as:

UCSG Bixby trains abortion to increase access (Image: Twitter)

According to Bixby, which was created to address a shortage of abortionists dating back to the mid 1980’s, the number of US abortion providers decreased by 38% between 1982 and 2005, and some 87% of US counties do not have an abortion provider.

Bixby runs two flagship programs, which “provide the opportunity to develop high-level research and clinical skills in abortion and contraception:”

FFP was established by Dr. Philip Darney, and as previously reported, FFP’s website makes it clear that abortion is their mission, stating that the family planning fellowship is a “two-year fellowship focused on subspecialist training in research, teaching and clinical practice in abortion and contraception… and they play an active role in discussions in the media related to family planning access and advocate for their patients in popular media outlets.”

Fellowship in Family Planning FFP FB Page (Image credit: Facebook)

Live Action News also previously reported how the Kenneth J. Ryan Residency Training Program in Abortion and Family Planning was founded in 1999 by Dr. Uta Landy, a former director of the National Abortion Federation and a recipient of Planned Parenthood Federation of America’s infamous Margaret Sanger Award. According to the Bixby Center, Landy established “one of the first abortion clinics in New York after legalization in 1970, and became the first executive director of the National Abortion Federation in 1979.” Landy was recently caught in undercover footage from the Center for Medical Progress talking about late-term abortions.

Philip Darney and Uta Landy at UCSF abortion training

The Ryan program is now at 70 major medical schools in the US and Canada, according to their website.

The Bixby Center was originally founded as the Center for Reproductive Health Research & Policy in 1999 by Philip Darney, MD and Nancy Padian, who were shortly thereafter joined by Claire Brindis, DrPH, MPH, and Felicia Stewart, MD, according to their report. The Center offers online abortion training courses and lectures through its Innovating Education in Reproductive Health which is described as “a digital hub that highlights innovative family planning and abortion curricula, tools, teaching techniques and research from educational leaders around the world.”

Innovating Education at UCSF abortion training

The group’s week by week abortion course, “Abortion Quality Care and Public Health Implications,” has a stated goal to destigmitize abortion, among other things. The “career planning brochure” instructs graduates to “moonlight” at abortion facilities and to “highlight [their] abortion training as a special skill set” when they apply to a practice.

Innovating Education Abortion Career Planning Brochure

The abortion training course is introduced by Jody Steinauer, Associate Professor at UCSF. The course is “directed at health care students and professionals.”

The video lectures lead up to the topic of  “abortion after the first trimester,” in week four, where Steinauer admits that later abortions “can be a difficult topic to discuss for many due to feelings about a more developed fetus.”

Jody Steinauer at UCSF abortion training

Despite the abortion industry’s frequent denial of facts about fetal development, Bixby’s TEACH Program (Training Early Abortion for Comprehensive Healthcare) workbook acknowledges that the fetal heartbeat can be detected very early, around six weeks gestation (dates used are gestational, which is measured at two weeks more than the date of fertilization):

The embryo follows a predictable path of development and therefore can be used to date a pregnancy based on its size. The embryo appears at approximately 6 weeks and grows 1 mm per day thereafter until 12-14 weeks. After 12 weeks, fetal flexion and extension make measuring length more challenging and using the fetal biparietal diameter (BPD) is preferred. Cardiac activity appears around 6 ½ weeks.

Bixby abortion training workbook TEACH

The workbook then gives suggestions on how to speak to an abortion patient about the baby. But because this is about ending the life of a developing human person in the womb, the workbook suggests abortion providers use euphemisms like “pregnancy” instead of scientifically correct terminology such as fetus or baby.

“Your pregnancy is 8 weeks along,” instead of  “Your baby is 8 weeks old.”

Bixby abortion training workbook TEACH communication

In upcoming Live Action News articles, we will highlight various teaching lectures published by the UCSF abortion training program.

    • This article is reprinted with permission. The original appeared here at Live Action News.

FDA: 24 women die from abortion pill, thousands of serious complications

Posted in AAPLOG, Abortion death, Abortion pill, Abortion Pill Connections, Abortion Pill Horrors, DANCO, Daniel Grossman, Generic Abortion Pill, Inc., Packard Foundation with tags , , , , , , , , , , , , , , , , , , , , , , , , on April 23, 2019 by saynsumthn

As more women die from abortion pill, the FDA approves a generic version

abortion pill, emergency contraception

 

The FDA has approved a generic version of the abortion pill Mifeprex, at a time when more deaths are being reported and the abortion industry is pushing for the dangerous abortion inducing chemicals to be dispensed online or by mail. According to a notice from the FDA, the generic version is approved for use as an abortifacient. This news comes just a day before the FDA updated its adverse effects reports through 2018, stating, “As of December 31, 2018, there were reports of 24 deaths of women associated with Mifeprex since the product was approved in September 2000, including two cases of ectopic pregnancy resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal…” The FDA’s 2017 report put the number of deaths at 22.

This means that in 2018 alone, two more women died from taking the abortion pill. And yet, now a generic version is going to be made available.

Abortion Pill Deaths December 2018

Dec 2018 abortion pill deaths FDA

To date, the report documents nearly 4,200 reported adverse effects, including hospitalization and other serious complications.

On April 11, 2019, the FDA approved GenBioPro, Inc.’s abbreviated new drug application for a generic Mifeprex, which, when used with Misoprostol is approved as an abortion pill regimen. The FDA states (emphasis added), “This approval reflects FDA’s determination that GenBioPro’s product, Mifepristone Tablets, 200 mg, is therapeutically equivalent to Mifeprex and can be safely substituted for Mifeprex. Like Mifeprex, the approved generic product is indicated for the medical termination of intrauterine pregnancy through 70 days gestation….”

READ: The secrecy surrounding the abortion pill’s maker and influential financial investors must end

Generic abortion pill by GenBioPro approved by FDA

The FDA also states clearly that although they modified the Mifeprex application to include “mifepristone products,” this change in no way removes the FDA’s REMS (Risk Evaluation and Mitigation Strategy), “a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use.”

Of note, on April 11, 2019, FDA approved a supplemental application for Mifeprex, approving modifications to the existing approved REMS for Mifeprex to establish a single, shared system REMS for mifepristone products (including Mifeprex as well as the approved generic version of Mifeprex) for the medical termination of intrauterine pregnancy through 70 days gestation. In establishing the single, shared system REMS, no changes were made to the substantive elements of the REMS. This single, shared system REMS is known as the Mifepristone REMS Program.

Find approval information for this 2019 supplement here.

The approved generic version of Mifeprex generally has the same labeling as Mifeprex…Under the law, the approved generic version of Mifeprex is required to use a single, shared system REMS with the brand product, Mifeprex. This single, shared system REMS, known as the Mifepristone REMS Program, sets forth the distribution requirements that must be followed for both Mifeprex and the approved generic version of Mifeprex.

Requiring that the generic be subject to FDA’s REMS is good news for now, because, as Live Action News has previously reported, the abortion lobby is attempting to expand access to the abortion pills via mail order or pharmacy by pushing “self-managed abortion,” described by Guttmacher as ending a pregnancy “without direct supervision by a health care provider.” To accomplish this, REMS, must be eliminated.

READ: What you should know about the dangerous ‘self-managed’ abortion pill push

Dr. Donna Harrison, Executive Director American Association of Pro-Life Obstetricians and Gynecologists(AAPLOG), agreed, telling Live Action News (emphasis added):

Allowing a generic equivalent of Mifeprex basically means that the patent restrictions have run out. So, new drugs have a patent which is time limited… and in the case of Mifeprex, the patent was held by the Population Council. So, now that the patent has run out, generics are allowed. But this does not change the restrictions. REMS are still in place until FDA changes the restrictions. So, just to clarify, this does not mean that Mifeprex is OTC [over-the-counter]. It just changes how much quality control goes in to the pill manufacturing process and how much Danco can charge for the drug.

The move towards a generic drug is being hailed a victory by abortion advocates, specifically Dr. Daniel Grossman, who has deep tiesto the “self-managed” abortion pill push.

Image: FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

FDA Approves generic abortion drug (Image Twitter Dr. Daniel Grossman)

Image: FDA Approves generic abortion drug NWHC (Image: Twitter)

FDA Approves generic abortion drug NWHC (Image: Twitter)

Under the Mifepristone REMS Program, the FDA states, “Mifeprex and the approved generic version of Mifeprex” may:

  • [O]nly be supplied directly to healthcare providers who are certified to prescribe the drug product and who meet certain qualifications.
  • [T]he products are only available to be dispensed in certain healthcare settings, specifically, clinics, medical offices and hospitals, by or under the supervision of a certified prescriber.
  • They are not available in retail pharmacies and are not legally available over the Internet.

The original drug (Mifeprex) was approved in 2000 after being brought to the U.S. by the eugenics-founded Population Council, and was seeded by the Packard Foundation among other pro-abortion philanthropy groups. They then set up a highly secretive company named Danco to manufacturer the drug.

The generic version is produced by GenBioPro, Inc., which also appears to have the financial support of abortion collaborators. In fact, Packard gave GenBioPro, Inc. $185,000 in 2016 and 100,000 in 2017. According to the Nevada Secretary of State, a 2007 filing for the company was permanently revoked. A new filing in 2011 is active and shows a registered agent of CSC Services of Nevada, Inc. and the only officer listed is E. Masingill.

The FDA warns consumers they should not buy Mifeprex or GenBioPro, Inc.’s approved generic version of Mifeprex, Mifepristone Tablets, 200 mg., over the Internet because they will bypass important safeguards designed to protect patient health.

    • This article is reprinted with permission. The original appeared here at Live Action News.